Patents by Inventor Diego Walther

Diego Walther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Tryptophan Derivatives for the Specific Cytostatic Treatment of Serotonin-Producing Tumors
    Publication number: 20070299128
    Abstract: The invention relates to the use of tryptophane-derivatives for the specific cytostatic treatment of serotonin-producing tumors, such as, for example carcinoids and the like. Areas of application of the invention are in the field of medicine and pharmaceutical industry.
    Type: Application
    Filed: August 30, 2007
    Publication date: December 27, 2007
    Inventors: Diego Walther, Michael Bader
  • Neuronally expressed tryptophane hydroxylase and its use
    Publication number: 20060275759
    Abstract: The present invention relates to novel, specifically neuronal expressed proteins with tryptophane hydroxylase activity, nucleic acid sequences, recombinant nucleic acid molecules containing these nucleic acid sequences or vectors containing these nucleic acid sequences or the recombinant nucleic acid molecules encoding for a neuronal tryptophane hydroxylase. The invention also relates to transgenic organisms containing these nucleic acid sequences, the recombinant nucleic acid molecules or the above cited vectors. The invention moreover refers to mono- or polyclonal antibodies directed against the isolated proteins. Furthermore, the invention relates to the use of these nucleic acid sequences and proteins for diagnosis, predisposition, therapy and monitoring of neuronal diseases. Possible fields of application among others are medicine and the pharmaceutical industry.
    Type: Application
    Filed: July 16, 2003
    Publication date: December 7, 2006
    Inventors: Diego Walther, Michael Bader
  • Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency
    Patent number: 7049336
    Abstract: Pharmaceutical compositions for treatment of primary hemostasis deficiency and methods of treatment of primary hemostasis deficiency are disclosed. Also, methods for diagnosing neuronal diseases and for suppressing the immune system are disclosed. Isoforms responsible for maintaining primary hemostasis, T-cell mediated immune responses, neuron specific TPH, and a neuronal tryptophan hydroxylase are disclosed.
    Type: Grant
    Filed: August 27, 2001
    Date of Patent: May 23, 2006
    Assignee: Max-Delbruck-Centrum fur Molekularc Medizin
    Inventors: Diego Walther, Michael Bader
  • Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors
    Publication number: 20040097576
    Abstract: The invention relates to the use of tryptophane-derivatives for the specific cytostatic treatment of serotonin-producing tumors, such as, for example carcinoids and the like. Areas of application of the invention are in the field of medicine and pharmaceutical industry.
    Type: Application
    Filed: September 12, 2003
    Publication date: May 20, 2004
    Inventors: Diego Walther, Michael Bader